HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In Vitro Anticancer Properties of Copper Metallodendrimers.

Abstract
Newly synthesized carbosilane copper dendrimers (CCD) with chloride and nitrate surface groups seem to be good candidates to be used as gene and drug carriers in anti-cancer therapy, due to their properties such as size and surface charge. Copper attached to the nanoparticles is an important element of many biological processes and recently their anti-cancer properties have been widely examined. Zeta size and potential, transmission electron microscopy (TEM), circular dichroism (CD), analysis of haemolytic activity, and fluorescence anisotropy techniques were used to characterize copper dendrimers. Additionally, their cytotoxic properties toward normal (PBMC) and cancer (1301; HL-60) cells were examined. All tested dendrimers were more cytotoxic against cancer cells in comparison with normal cells.
AuthorsMarcin Hołota, Jakub Magiera, Sylwia Michlewska, Małgorzata Kubczak, Natalia Sanz Del Olmo, Sandra García-Gallego, Paula Ortega, F Javier de la Mata, Maksim Ionov, Maria Bryszewska
JournalBiomolecules (Biomolecules) Vol. 9 Issue 4 (04 18 2019) ISSN: 2218-273X [Electronic] Switzerland
PMID31003561 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Dendrimers
  • Copper
Topics
  • Antineoplastic Agents (chemistry, pharmacology, toxicity)
  • Cell Line, Tumor
  • Cells, Cultured
  • Copper (chemistry)
  • Dendrimers (chemistry, pharmacology, toxicity)
  • Hemolysis
  • Humans
  • Monocytes (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: